UKBizDB.co.uk

BIAPHARMA LLP

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Biapharma Llp. The company was founded 8 years ago and was given the registration number OC403470. The firm's registered office is in LONDON. You can find them at 99 Castelnau, Barnes, London, . This company's SIC code is None Supplied.

Company Information

Name:BIAPHARMA LLP
Company Number:OC403470
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:16 December 2015
End of financial year:31 March 2024
Jurisdiction:England - Wales
Industry Codes:
  • None Supplied

Office Address & Contact

Registered Address:99 Castelnau, Barnes, London, United Kingdom, SW13 9EL
Country Origin:UNITED KINGDOM
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
99, Castelnau, Barnes, London, United Kingdom, SW13 9EL

Llp Designated Member16 December 2015Active
99, Castelnau, Barnes, London, United Kingdom, SW13 9EL

Llp Designated Member16 December 2015Active

People with Significant Control

Mr Mark Dexter Clark
Notified on:15 December 2016
Status:Active
Date of birth:July 1963
Nationality:British
Country of residence:England
Address:99, Castelnau, London, England, SW13 9EL
Nature of control:
  • Significant influence or control limited liability partnership
Mrs Jayne Clark
Notified on:15 December 2016
Status:Active
Date of birth:June 1958
Nationality:British
Country of residence:England
Address:99, Castelnau, London, England, SW13 9EL
Nature of control:
  • Significant influence or control limited liability partnership

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (4 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (9 months ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (2 months remaining)

Copyright © 2024. All rights reserved.